Notes to SEFA
Title: Loan/loan guarantee outstanding balances
Accounting Policies: The accompanying schedule of expenditures of federal awards (the "schedule") includes the federal award activity of CDC Small Business Finance Corp. ("CDC") under programs of the federal government for the year ended December 31, 2022. The information is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards ("Uniform Guidance"). Because the Schedule presents only a selected portion of the operations of CDC, it is not intended to and does not present the financial position, changes in net assets or cash flows of CDC. Expenditures reported in the Schedule are reported on the accrual basis of accounting. When applicable, such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. No federal financial assistance has been provided to a subrecipient.
De Minimis Rate Used: N
Rate Explanation: CDC has not elected to use the 10% de minimus cost rate as allowed under the Uniform Guidance.
MICROLOAN PROGRAM (59.046) - Balances outstanding at the end of the audit period were 310369. MICROLOAN PROGRAM (59.046) - Balances outstanding at the end of the audit period were 470870. MICROLOAN PROGRAM (59.046) - Balances outstanding at the end of the audit period were 733531. MICROLOAN PROGRAM (59.046) - Balances outstanding at the end of the audit period were 1814814.
Title: Microloan Program
Accounting Policies: The accompanying schedule of expenditures of federal awards (the "schedule") includes the federal award activity of CDC Small Business Finance Corp. ("CDC") under programs of the federal government for the year ended December 31, 2022. The information is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards ("Uniform Guidance"). Because the Schedule presents only a selected portion of the operations of CDC, it is not intended to and does not present the financial position, changes in net assets or cash flows of CDC. Expenditures reported in the Schedule are reported on the accrual basis of accounting. When applicable, such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. No federal financial assistance has been provided to a subrecipient.
De Minimis Rate Used: N
Rate Explanation: CDC has not elected to use the 10% de minimus cost rate as allowed under the Uniform Guidance.
The Microloan Program represents a program under which the CDC periodically applies for and receives loan proceeds from the Small Business Administration ("SBA") (revolving loan pools) that are used to make microloans to eligible micro-borrowers. These microloans are made in accordance with guidance set forth by the SBA under its Standard Operating Procedures ("SOP") and require CDC to meet continuing compliance and reporting requirements. In addition, each fiscal year, CDC applies for and receives approval for grant funding to be paid on a reimbursement basis for specific technical assistance-related expenses incurred by the CDC with respect to the Microloan Program.
Title: Community Development Block Grant ("CDBG") Program
Accounting Policies: The accompanying schedule of expenditures of federal awards (the "schedule") includes the federal award activity of CDC Small Business Finance Corp. ("CDC") under programs of the federal government for the year ended December 31, 2022. The information is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards ("Uniform Guidance"). Because the Schedule presents only a selected portion of the operations of CDC, it is not intended to and does not present the financial position, changes in net assets or cash flows of CDC. Expenditures reported in the Schedule are reported on the accrual basis of accounting. When applicable, such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. No federal financial assistance has been provided to a subrecipient.
De Minimis Rate Used: N
Rate Explanation: CDC has not elected to use the 10% de minimus cost rate as allowed under the Uniform Guidance.
For the year ended December 31, 2022, the City of San Diego approved and entered into an agreement with CDC and with Bankers Small Business CDC ("Bankers") to initiate and implement a Citywide Economic Development Impact Program. This agreement is a Small Business Revolving Loan and Business Advising Services Agreement under which the CDC is a subrecipient of federal monies from the Department of Housing and Urban Development ("HUD") under the CDBG Program, passed-through the City of San Diego. The Revolving Loan Fund is intended to provide small business loans for eligible borrowers, and for eligible purpose, within the City of San Diego, with Bankers Small Business CDC providing 50% of loan funding disbursed. The Business Assistance Fund is intended to cover CDC's expenses related to identifying eligible borrowers through approved business partners, and to provide business and technical advice assistance to borrowers or potential borrower within the City of San Diego.